In primary tumors, nuclear expression of YAP has been shown to be significantly associated with tumor recurrence after primary treatment 8, while YAP has also been shown to be upregulated and markedly hyperactivated in castration-resistant prostate tumors compared with primary tumors 9. The gene discussed is YAP1; the disease is neoplasm.